vitamin c
Approved
Jul 28, 1947
Magnesium ascorbate is a non-acidic buffered form of Vitamin C and a source of the essential mineral Magnesium. The in vitro model system consisted of the isolated section of rat small intestine. The sources of magnesium ion (Mg2+) were magnesium chloride, magnesium sulphate, magnesium acetate, magnesium lactate, magnesium hydrocitrate and magnesium ascorbate. Magnesium ions from magnesium ascorbate were absorbed after the first 15 minutes to the highest extent of all salts, but after 120 minutes their absorption was the smallest of all. The use of magnesium ascorbate in food supplements may lead to an additional exposure to vitamin C and Magnesium. — NCATS
Clinical trial activity
635 trials · 651 clinical orgs · 14 marketing orgs
Earliest trial started Sep 1, 1992 (NCT00000539)
Timeline
1940s
1980s
- Nov 6, 1981
Abraxis — Marketing Organization
- Nov 6, 1981
Abraxis — NDA Secondary Org
- Jul 13, 1982
Watson Pharmaceuticals — Marketing Organization
- Jul 13, 1982
Watson Pharmaceuticals — NDA Secondary Org
1990s
2000s
2010s
- Jan 25, 2012
Novel Anti-Infective Technologies, LLC — Marketing Organization
- Oct 2, 2017
McGuff Pharmaceuticals — NDA Secondary Org
- May 4, 2018
Bausch Health Companies — NDA Secondary Org
2020s
- Jun 28, 2024
Taro Pharmaceuticals — Marketing Organization
- Aug 7, 2025
Fresenius — Marketing Organization
- Apr 9, 2026
Apotex — Marketing Organization
Indications
Approved for
Studied for
- Ablation Techniques · Phase 2
- Achlorhydria · Phase 1
- Acidosis, Lactic · Phase 2/Phase 3
- Acne Vulgaris · Phase 1/Phase 2
- Acute Kidney Injury · Phase 4
- Acute Lung Injury · Phase 2
- Acute Pain · Early Phase 1
- Adenocarcinoma · Phase 2
- Aging · Phase 4
- Albuminuria · Phase 2
- Alcohol Withdrawal Delirium · Phase 2/Phase 3
- Alveolar Bone Loss · Phase 2
- Alzheimer Disease · Phase 1
- Anemia, Iron-Deficiency · Phase 4
- Angina Pectoris · Phase 4
- Anti-Infective Agents, Local · Phase 2
- Antioxidants · Phase 4
- Appetite · Phase 3
- Arterial Occlusive Diseases · Phase 3
- Arthritis, Rheumatoid · Phase 3
- Ascorbic Acid · Phase 4
- Ascorbic Acid Deficiency · Phase 2
- Aspirin · Phase 4
- Asthma · Phase 2
- Astrocytoma · Phase 1
- Atherosclerosis · Phase 2
- Atrial Fibrillation · Phase 4
- Atrial Flutter · Phase 3
- Attention Deficit Disorder with Hyperactivity · Phase 2/Phase 3
- Autistic Disorder · Phase 1
- Avitaminosis · Phase 2
- Basal Cell Carcinoma · Early Phase 1
- beta-Thalassemia · Phase 2/Phase 3
- Biomarkers · Phase 2
- Bleeding Time · Phase 2
- Blood Pressure · Early Phase 1
- Body Fluids · Phase 4
- Bone and Bones · Phase 2/Phase 3
- Brain Injuries · Phase 2
- BRCA1 Protein · Phase 2
- Breast Neoplasms · Phase 2
- Bronchiolitis Obliterans Syndrome · Phase 3
- Burns · Phase 2
- Carcinoma · Phase 2
- Carcinoma, Hepatocellular · Phase 3
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Renal Cell · Phase 2
- Carcinoma, Squamous Cell · Early Phase 1
- Cardiovascular Diseases · Phase 4
- Carotid Artery Diseases · Phase 2
- Cataract · Phase 3
- Catheter-Related Infections · Phase 2
- Central Serous Chorioretinopathy · Phase 2
- Cerebrovascular Disorders · Phase 2
- Charcot-Marie-Tooth Disease · Phase 2/Phase 3
- Cholecystitis · Phase 4
- Chronic Pain · Phase 2
- Clonal Hematopoiesis · Phase 2
- Cognition · Phase 4
- Colitis, Ulcerative · Phase 4
- Colon · Phase 4
- Colonic Diseases · Phase 4
- Colonic Neoplasms · Phase 3
- Colonic Polyps · Phase 3
- Colonoscopy · Phase 4
- Colorectal Neoplasms · Phase 4
- Common Cold · Phase 4
- Constipation · Phase 2
- Contusions · Phase 4
- Coronary Artery Bypass · Phase 1
- Coronary Artery Disease · Phase 4
- Coronary Disease · Phase 3
- Coronavirus · Phase 3
- Coronavirus Infections · Phase 4
- COVID-19 · Phase 4
- C-Reactive Protein · Phase 3
- Critical Illness · Phase 4
- Cystic Fibrosis · Phase 2
- Deficiency Diseases · Phase 2/Phase 3
- Depression · Phase 2
- Dermatology · Phase 4
- Desmoplastic Small Round Cell Tumor · Phase 2
- Diabetes, Gestational · Phase 4
- Diabetes Mellitus · Phase 4
- Diabetes Mellitus, Type 1 · Phase 4
- Diabetes Mellitus, Type 2 · Phase 4
- Diabetic Foot · Phase 4
- Diabetic Neuropathies · Phase 1
- Diabetic Retinopathy · Phase 3
- Diarrhea · Phase 2
- Dietary Supplements · Phase 4
- Eclampsia · Phase 3
- Endometriosis · Phase 2
- Endoscopy · Phase 2/Phase 3
- Endothelial Cells · Phase 1
- Endothelium · Phase 4
- Enteral Nutrition · Phase 2/Phase 3
- Epilepsy · Phase 2
- Exercise Tolerance · Phase 2/Phase 3
- Fatigue · Phase 2/Phase 3
- Fatigue Syndrome, Chronic · Phase 4
- Fatty Liver · Phase 1
- Fever · Phase 4
- Fibrosis · Phase 2/Phase 3
- Fractures, Bone · Phase 4
- Fragile X Syndrome · Phase 3
- Frailty · Phase 2
- Gastroenteritis · Phase 3
- General Surgery · Phase 1
- Geroscience · Phase 2/Phase 3
- Gingival Diseases · Phase 4
- Glioblastoma · Phase 2
- Glioma · Phase 3
- Gliosarcoma · Phase 1
- Glucagon-Like Peptide 1 · Phase 2/Phase 3
- Glycemic Control · Phase 2
- Graft vs Host Disease · Early Phase 1
- Graves Ophthalmopathy · Phase 2/Phase 3
- Growth and Development · Phase 1
- Growth Hormone · Phase 2
- Healthcare-Associated Pneumonia · Phase 2
- Healthy Volunteers · Phase 4
- Hearing Loss, Noise-Induced · Phase 2
- Heart Arrest · Phase 2
- Heart Disease Risk Factors · Phase 1
- Heart Diseases · Phase 3
- Heart Failure · Phase 3
- Heart Valve Diseases · Phase 1
- Helicobacter pylori · Phase 4
- HELLP Syndrome · Phase 3
- Hemodialysis, Home · Phase 2
- Hemorrhage · Phase 3
- Hepatitis, Alcoholic · Phase 4
- Hepatitis C, Chronic · Phase 4
- Hepatitis, Chronic · Phase 4
- Hereditary Sensory and Motor Neuropathy · Phase 2
- HIV · Phase 2
- Hodgkin Disease · Phase 2
- Hospitalization · Phase 3
- Humans · Phase 2
- Hypercapnia · Phase 1
- Hypertension · Phase 1/Phase 2
- Hypertension, Pulmonary · Phase 1
- Hypotension · Phase 1/Phase 2
- Hypothyroidism · Phase 2
- Hypoxia · Phase 1/Phase 2
- Hysterectomy · Phase 3
- Immune System · Phase 2
- Immunologic Factors · Phase 2
- Infant, Premature · Phase 3
- Infertility, Male · Phase 4
- Inflammation · Phase 4
- Inflammatory Bowel Diseases · Phase 3
- Influenza A Virus, H1N1 Subtype · Phase 4
- Influenza, Human · Phase 4
- Insulin Resistance · Phase 2/Phase 3
- Intensive Care Units · Phase 3
- Intermittent Claudication · Phase 1
- Intestinal Neoplasms · Early Phase 1
- Intestine, Large · Phase 4
- Intracranial Arteriosclerosis · Phase 2
- Iron Deficiencies · Phase 3
- Iron Overload · Phase 4
- Kidney Calculi · Phase 4
- Kidney Diseases · Phase 2
- Kidney Failure, Chronic · Phase 3
- Laparoscopy · Phase 4
- Lead Poisoning · Phase 2/Phase 3
- Leiomyoma · Phase 3
- Leukemia · Phase 2
- Leukemia, Lymphoid · Phase 2
- Leukemia, Monocytic, Acute · Phase 2
- Leukemia, Myeloid · Phase 2
- Leukemia, Myeloid, Acute · Phase 2
- Leukemia, Myelomonocytic, Chronic · Phase 2
- Live Birth · Phase 4
- Liver Neoplasms · Phase 2
- Liver Transplantation · Phase 4
- Longevity · Phase 2/Phase 3
- Lung Diseases · Phase 2/Phase 3
- Lung Neoplasms · Phase 2
- Lung Transplantation · Phase 2
- Lymphoma · Phase 2
- Lymphoma, B-Cell · Phase 2
- Lymphoma, Large B-Cell, Diffuse · Phase 2
- Lymphoma, Non-Hodgkin · Phase 2
- Macular Degeneration · Phase 3
- Magnesium Deficiency · Phase 2/Phase 3
- Magnesium Sulfate · Phase 2
- Malnutrition · Phase 3
- Melanoma · Early Phase 1
- Melanosis · Phase 2
- Metabolic Diseases · Phase 3
- Metabolic Syndrome · Phase 4
- Migraine Disorders · Phase 3
- Multiple Myeloma · Phase 2
- Multiple Organ Failure · Phase 4
- Mutation · Phase 2
- Mycobacterium tuberculosis · Phase 3
- Myelodysplastic-Myeloproliferative Diseases · Phase 2
- Myelodysplastic Syndromes · Phase 2
- Myeloproliferative Disorders · Phase 2
- Myocardial Infarction · Phase 2
- Myocardial Ischemia · Phase 3
- Neoplasm Metastasis · Phase 2
- Neoplasms · Phase 3
- Neoplasms, Squamous Cell · Early Phase 1
- Neuralgia · Phase 2
- Neurosurgical Procedures · Phase 2
- Nicotine · Phase 2/Phase 3
- Obesity · Phase 4
- Obstetric Labor Complications · Phase 4
- Oligodendroglioma · Phase 1
- Osteosarcoma · Phase 2
- Out-of-Hospital Cardiac Arrest · Phase 2
- Ovarian Neoplasms · Phase 2
- Oxalates · Phase 4
- Oxidative Stress · Phase 3
- Pain · Phase 3
- Pain Perception · Phase 1
- Palliative Care · Phase 2
- Pancreatic Neoplasms · Phase 4
- Pancreatitis · Phase 2/Phase 3
- Pandemics · Phase 3
- Periodontitis · Phase 2
- Peripheral Arterial Disease · Phase 1
- Peripheral Vascular Diseases · Phase 1
- Peritoneal Dialysis · Phase 3
- Pharmacokinetics · Phase 1
- Pharmacological and Toxicological Phenomena · Phase 3
- Plasma · Phase 1
- Pneumonia · Phase 2
- Pneumonia, Ventilator-Associated · Phase 2
- Pneumonia, Viral · Phase 2
- Polycythemia Vera · Phase 1
- Post-Cardiac Arrest Syndrome · Phase 2
- Postmenopause · Phase 3
- Postoperative Complications · Phase 2
- Postoperative Pain · Phase 4
- Postpartum Hemorrhage · Early Phase 1
- Postural Orthostatic Tachycardia Syndrome · Early Phase 1
- Pre-Eclampsia · Phase 3
- Pregnancy · Phase 3
- Pregnancy Complications · Phase 4
- Prehypertension · Phase 2
- Primary Graft Dysfunction · Phase 2
- Primary Myelofibrosis · Phase 1
- Prostatic Neoplasms · Phase 2
- Prostatic Neoplasms, Castration-Resistant · Phase 2
- Prostheses and Implants · Phase 2
- Psychological Distress · Phase 1
- Psychotic Disorders · Phase 2/Phase 3
- Pulmonary Alveolar Proteinosis · Phase 1/Phase 2
- Pulmonary Disease, Chronic Obstructive · Phase 2
- Purpura, Thrombocytopenic, Idiopathic · Phase 2/Phase 3
- Rectal Neoplasms · Phase 2
- Reflex Sympathetic Dystrophy · Phase 4
- Renal Insufficiency · Phase 4
- Renal Insufficiency, Chronic · Phase 4
- Reperfusion Injury · Phase 4
- Respiratory Distress Syndrome · Phase 3
- Respiratory Insufficiency · Phase 2
- Respiratory Tract Infections · Phase 3
- Restless Legs Syndrome · Phase 3
- Root Resorption · Phase 1
- Rotator Cuff Injuries · Phase 4
- Safety · Phase 1
- Sarcoma · Phase 2
- SARS-CoV-2 · Phase 4
- Schizophrenia · Phase 4
- Secretory Vesicles · Phase 1
- Semen Analysis · Phase 4
- Sepsis · Phase 4
- Severe Acute Respiratory Syndrome · Phase 3
- Shock · Phase 2
- Shock, Septic · Phase 4
- Shoulder Injuries · Phase 4
- Signs and Symptoms, Respiratory · Phase 2/Phase 3
- Skin Aging · Phase 2/Phase 3
- Skin Neoplasms · Early Phase 1
- Sleep Apnea Syndromes · Early Phase 1
- Smoking · Phase 2
- Spinal Cord Injuries · Phase 4
- Spinal Diseases · Early Phase 1
- Sprains and Strains · Phase 2
- Stem Cell Transplantation · Phase 1/Phase 2
- Stomach Neoplasms · Phase 3
- Stomatitis · Phase 2/Phase 3
- Stress, Psychological · Phase 4
- Stroke · Phase 4
- Subarachnoid Hemorrhage · Phase 3
- Systemic Inflammatory Response Syndrome · Phase 4
- Temporomandibular Joint Disorders · Phase 1/Phase 2
- Thoracic Surgery · Phase 4
- Thrombocythemia, Essential · Phase 1
- Tobacco Smoke Pollution · Phase 2/Phase 3
- Tracheostomy · Phase 1
- Transfusion-Related Acute Lung Injury · Phase 2
- Tuberculosis · Phase 2
- Ultraviolet Rays · Phase 1
- Uremia · Phase 4
- Urinary Bladder Neoplasms · Phase 2
- Urinary Tract Infections · Phase 4
- Urological Manifestations · Phase 2
- Uterine Cervical Neoplasms · Phase 2
- Uterine Neoplasms · Phase 2
- Vascular Diseases · Phase 3
- Vascular Stiffness · Early Phase 1
- Vasoconstriction · Phase 1
- Vasodilation · Early Phase 1
- Vasoplegia · Phase 2
- Ventilator-Induced Lung Injury · Phase 2
- Vitamin D Deficiency · Phase 2
- Weight Loss · Phase 4
- Wernicke Encephalopathy · Phase 2/Phase 3
- Wounds and Injuries · Phase 4
Mechanism of action
- Unspecified targetOTHER
Supplement
Provides a source of ascorbic acid and restores depleted ascorbic acid resources.
Combination products
berocca pn
with vitamin e, folic acid, cyanocobalamin, nicotinamide, thiamine, biotin, panthenol, pyridoxine, riboflavin, vitamin a, ergocalciferol
Also known as m.v.c, mvc plus
infuvite
with vitamin d3, vitamin e, folic acid, cyanocobalamin, nicotinamide, thiamine, vitamin k, biotin, panthenol, pyridoxine, riboflavin, vitamin a
Also known as infuvite pediatric, infuvite pediatric (pharmacy bulk package)
moviprep
with potassium chloride, sodium sulfate, sodium chloride, polyethylene glycol
Also known as peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic aci, plenvu
m.v.i. adult (pharmacy bulk package)
with vitamin e, folic acid, cyanocobalamin, nicotinamide, thiamine, vitamin k, biotin, panthenol, pyridoxine, riboflavin, vitamin a, ergocalciferol
m.v.i. pediatric
with vitamin e, folic acid, cyanocobalamin, nicotinamide, thiamine, biotin, panthenol, pyridoxine, riboflavin, vitamin a, phytonadione, ergocalciferol
vitape
with vitamin e, folic acid, cyanocobalamin, nicotinamide, thiamine, pantothenic acid, biotin, pyridoxine, riboflavin, vitamin a, phytonadione, ergocalciferol
Approval history
- approvedJul 28, 1947
Chemistry & pharmacology
SMILES
[Mg++].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]2OC(=O)C(O)=C2[O-]- Mol. weight
- 374.5374 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral, Parenteral
- Availability
- Prescription Only
Oral
Yes
Parenteral
Yes
Topical
No
Sources
- WikipediaVitamin C ↗
- NCATS0N1G678593 ↗
- ChEMBLCHEMBL591665 ↗
- ChEMBLCHEMBL2146095 ↗
- ChEMBLCHEMBL196 ↗
- NCATSPQ6CK8PD0R ↗
Also known as
- acide ascorbique
- acide ascorbique
- ácido ascórbico
- ácido ascórbico
- acidum ascorbicum
- acidum ascorbicum
- acidum ascorbinicum
- acidum ascorbinicum
- apetiviton
- ascorbate
- ascorbate
- ascorbate
- ascorbate
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid
- ascorbic acid, monosodium salt
- ascorbic acid (vit c)
- ascorbic acid (vit c)
- ascorbic acid (vit c)
- ascorbicap
- ascorbicap
- ascorbicap
- ascorbin
- ascorbin
- ascorbinsäure
- ascorbinsäure
- ascur
- bassett's
- calcium ascorbate
- cebione
- cebione
- cecon
- cecon
- cenolate
- cenolate
- cetane
- cetane
- cetane-caps tc
- cetane-caps tc
- cevalin
- cevalin
- cevex
- cevex
- cevitamic acid
- cevitamic acid
- chick pea extractvitamin c, l-leucine, vegetable capsule (hypromellose)
- e300
- e300
- e301
- e301
- enantic acid
- enantic acid
- haliborange
- kaprylsaeure
- kaprylsaeure
- l-ascorbate
- l-ascorbate
- l-ascorbate
- l-(+)-ascorbic acid
- l-(+)-ascorbic acid
- l-ascorbic acid
- l-ascorbic acid
- l-ascorbic acid
- l-ascorbic acid
- lithium octanoate
- n-capric acid
- n-capric acid
- n-caprylic acid
- n-caprylic acid
- n-decanoic acid
- n-decanoic acid
- neo-fat 8
- neo-fat 8
- peg-ascorbate
- redoxon
- redoxon
- redoxon c
- redoxon chew-c
- redoxon slow release
- sodium ascorbate
- sodium ascorbate
- sodium ascorbate
- sodium ascorbate
- sodium octanoate
- top c
- vital life
- vitamin c
- vitamin c
- vitamin c
- vitamin c
- vitamin c
- vitamin c
- vitamin c
- vitamin c
- vitamins c
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07283900 | Phase 2 | May 1, 2026 | University of Iowa |
| NCT07197749 | Early Phase 1 (Phase 1) | Jan 31, 2026 | Baylor University, The University of Texas, Dallas |
| NCT07177079 | Phase 1 | Dec 31, 2025 | University of Iowa |
| NCT07285109 | N/A | Dec 22, 2025 | Qualia Life Sciences |
| NCT07302828 | N/A | Dec 15, 2025 | TCI Co., Ltd. |
| NCT07184866 | N/A | Oct 31, 2025 | Institute of Liver and Biliary Sciences, India |
| NCT07151105 | N/A | Oct 1, 2025 | Ohio State University |
| NCT06995586 | N/A | Sep 1, 2025 | Cyprus University of Technology, Government of Russia, University of Cyprus |
| NCT07109115 | N/A | Sep 1, 2025 | University of Virginia |
| NCT06823999 | Phase 4 | Aug 1, 2025 | Chiayi Christian Hospital |
| NCT07070024 | Phase 1/Phase 2 (Phase 2) | Jul 31, 2025 | Fayoum University |
| NCT06971315 | Early Phase 1 (Phase 1) | Jun 2, 2025 | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal |
| NCT06989320 | N/A | May 27, 2025 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The University of Texas, Dallas, University of Alabama, Birmingham |
| NCT06968936 | N/A | May 15, 2025 | Chongqing Medical University, Nanjing Medical University, Wenzhou Medical University, Zhejiang University |
| NCT06985394 | N/A | May 14, 2025 | University of Delaware |
| NCT06936592 | N/A | Apr 17, 2025 | Minia University |
| NCT07121036 | Phase 1 | Mar 30, 2025 | Xiamen University |
| NCT06857734 | N/A | Mar 1, 2025 | Benha University |
| NCT06897384 | N/A | Mar 1, 2025 | Jiao Tong University, Shanghai Municipal Science and Technology Commission |
| NCT06847880 | Phase 1 | Feb 23, 2025 | University of Baghdad |
Organizations
Research & Development (651)
Marketing (23)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Abraxis | For profit | MKTG | Nov 6, 1981 |
| Abraxis | For profit | NDA2 | Nov 6, 1981 |
| Apotex | For profit | MKTG | Apr 9, 2026 |
| Bausch Health Companies | For profit | NDA2 | May 4, 2018 |
| Fresenius | For profit | MKTG | Aug 7, 2025 |
| Hospira | For profit | MKTG | Feb 20, 1953 |
| Hospira | For profit | NDA2 | Feb 20, 1953 |
| McGuff Pharmaceuticals | For profit | NDA2 | Oct 2, 2017 |
| Novartis | For profit | NDA2 | May 18, 2000 |
| Novel Anti-Infective Technologies, LLC | For profit | MKTG | Jan 25, 2012 |
| Roche | For profit | MKTG | Jul 28, 1947 |
| Roche | For profit | NDA2 | Jul 28, 1947 |
| Roche | For profit | NDA | Jul 28, 1947 |
| Salix | For profit | MKTG | Aug 2, 2006 |
| Salix | For profit | SYN | May 4, 2018 |
| Salix | For profit | SYN | May 4, 2018 |
| Salix | For profit | NDA2 | Aug 2, 2006 |
| Sandoz | For profit | MKTG | May 18, 2000 |
| Sandoz | For profit | NDA2 | May 18, 2000 |
| Taro Pharmaceuticals | For profit | MKTG | Jun 28, 2024 |
| Teligent Pharmaceuticals | For profit | NDA2 | — |
| Watson Pharmaceuticals | For profit | MKTG | Jul 13, 1982 |
| Watson Pharmaceuticals | For profit | NDA2 | Jul 13, 1982 |